Acute toxicity profile of patients with low-grade gliomas and meningiomas receiving proton therapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 37, Issue 5, 2013, Pages 438-443

  Maquilan, Genevieve ^a   Grover, Surbhi ^a   Alonso Basanta, Michelle ^a   Lustig, Robert A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Central nervous system neoplasms; Low grade glioma; Meningioma; Protons; Radiation oncology; Toxicity

Indexed keywords

EID: 84914691563     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31827de86b     Document Type: Article

References (11)

1. CBTRUS. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. 2011. http://www.cbtrus.org.
2. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002;20:2267-2276.
3. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on doseresponse in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 1996;36:549-556.
4. Van Den Bent MJ, Afra D, De Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366:985-990.
5. Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer. 1998;34:1902-1909.
6. Taphoorn MJ, Heimans JJ, Snoek FJ, et al. Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry. 1992;55:372-376.
7. Van Kampen M, Engenhart-Cabillic R, Debus J, et al. Low-grade astrocytoma: treatment with conventionally fractionated stereotactic radiation therapy. Radiology. 1996;201:275-278.
8. Yavas C, Zorlu F, Ozyigit G, et al. Prospective assessment of health-related quality of life in patients with low-grade glioma: a single-center experience. Support Care Cancer. 2012;20:1859-1868.
9. Aaronson NK, Taphoorn MJ, Heimans JJ, et al. Compromised health-related quality of life in patients with low-grade glioma. J Clin Oncol. 2011;29:4430-4435.
10. Uy NW, Woo SY, Teh BS, et al. Intensity-modulated radiation therapy (IMRT) for meningioma. Int J Radiat Oncol Biol Phys. 2002;53:1265-1270.
11. Pirzkall A, Debus J, Haering P, et al. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skullbase meningiomas: preliminary clinical experience. Int J Radiat Oncol Biol Phys. 2003;55:362-372.